Airway mucus penetration and anti-inflammatory effects of charge-tunable nanocarriers in an asthma model
Frontiers in Biotechnology and Genetics · 2025-12-01 · 2 (1) · 45-50
DOI: 10.71465/fbg447 ↗At a glance
Journal article in Frontiers in Biotechnology and Genetics, published online on 2025-12-01. Written by Liam A. McKenzie and 2 co-authors. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
In asthma, thick airway mucus blocks drug movement and lowers treatment efficiency. In this study, lipid nanoparticles (LNPs) with different surface charges (+20 mV, 0 mV, and −20 mV) were made to test how charge affects mucus transport and anti-inflammatory action. The LNPs had an average size of 160 ± 12 nm and were studied in mice with ovalbumin (OVA)-induced asthma. Imaging results showed that neutral LNPs spread more evenly in the lungs and stayed for up to 8 hours, while positively and negatively charged ones cleared faster. Measurement of inflammation markers showed that the neutral group lowered IL-4 and IL-13 levels by about 65% (P < 0.001) compared with the positive group. These findings show that neutral charge helps nanoparticles pass through mucus, remain longer in the lungs, and produce stronger anti-inflammatory effects. This work provides a simple way to improve inhaled nanoparticle treatments for asthma and other airway diseases with mucus buildup.
Cite
APA
McKenzie, L. A., Roy, G., & Leblanc, A. J. (2025). Airway mucus penetration and anti-inflammatory effects of charge-tunable nanocarriers in an asthma model. Frontiers in Biotechnology and Genetics, 2(1), 45-50. https://doi.org/10.71465/fbg447
Vancouver
McKenzie LA, Roy G, Leblanc AJ. Airway mucus penetration and anti-inflammatory effects of charge-tunable nanocarriers in an asthma model. Frontiers in Biotechnology and Genetics. 2025;2(1):45-50. doi:10.71465/fbg447
BibTeX
@article{McKenzie2025,
author = {McKenzie, Liam A. and Roy, Gabriel and Leblanc, Amelia J.},
title = {Airway mucus penetration and anti-inflammatory effects of charge-tunable nanocarriers in an asthma model},
journal = {Frontiers in Biotechnology and Genetics},
year = {2025},
volume = {2},
number = {1},
pages = {45--50},
doi = {10.71465/fbg447}
}
EUVIMED